Matthew Sheerin
Stock Analyst at Needham
(3.85)
# 593
Out of 5,182 analysts
156
Total ratings
68.24%
Success rate
31.31%
Average return
Main Sectors:
Stocks Rated by Matthew Sheerin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 | $21.21 | +41.44% | 2 | Apr 10, 2025 | |
| CLS Celestica | Maintains: Buy | $140 → $150 | $294.84 | -49.12% | 13 | Feb 19, 2025 | |
| EVH Evolent Health | Initiates: Buy | $15 | $2.25 | +566.67% | 1 | Jan 10, 2025 | |
| AGL agilon health | Reiterates: Hold | n/a | $10.74 | - | 1 | Jan 10, 2025 | |
| JBL Jabil | Reiterates: Buy | $150 → $160 | $268.55 | -40.42% | 14 | Dec 19, 2024 | |
| PLXS Plexus | Maintains: Hold | $136 → $150 | $207.35 | -27.66% | 2 | Dec 10, 2024 | |
| FLEX Flex Ltd. | Maintains: Buy | $40 → $48 | $68.59 | -30.02% | 8 | Dec 10, 2024 | |
| HPE Hewlett Packard Enterprise Company | Maintains: Buy | $22 → $25 | $24.61 | +1.58% | 4 | Dec 6, 2024 | |
| PSTG Everpure | Maintains: Hold | $60 → $65 | $62.48 | +4.03% | 13 | Dec 4, 2024 | |
| NTAP NetApp | Maintains: Buy | $140 → $145 | $103.35 | +40.30% | 15 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $24.75 | +13.13% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $43 → $38 | $34.61 | +9.79% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $280 | $346.54 | -19.20% | 8 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $2.5 | $2.62 | -4.58% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $50 → $55 | $61.87 | -11.10% | 10 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $97.48 | -75.38% | 3 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $260 | $122.01 | +113.10% | 6 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.76 | +2,259.42% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $112 → $66 | $128.00 | -48.44% | 8 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $90 | $77.21 | +16.57% | 7 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $18.58 | +34.55% | 7 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $145 | $209.07 | -30.65% | 2 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $120 | $186.92 | -35.80% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $315 | $452.07 | -30.32% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $150 | $67.05 | +123.71% | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $130 → $105 | $145.85 | -28.01% | 11 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $20 | $13.58 | +47.28% | 1 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $20 | $0.58 | +3,248.79% | 2 | Nov 27, 2019 |
Privia Health Group
Apr 10, 2025
Reiterates: Buy
Price Target: $30
Current: $21.21
Upside: +41.44%
Celestica
Feb 19, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $294.84
Upside: -49.12%
Evolent Health
Jan 10, 2025
Initiates: Buy
Price Target: $15
Current: $2.25
Upside: +566.67%
agilon health
Jan 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $10.74
Upside: -
Jabil
Dec 19, 2024
Reiterates: Buy
Price Target: $150 → $160
Current: $268.55
Upside: -40.42%
Plexus
Dec 10, 2024
Maintains: Hold
Price Target: $136 → $150
Current: $207.35
Upside: -27.66%
Flex Ltd.
Dec 10, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $68.59
Upside: -30.02%
Hewlett Packard Enterprise Company
Dec 6, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $24.61
Upside: +1.58%
Everpure
Dec 4, 2024
Maintains: Hold
Price Target: $60 → $65
Current: $62.48
Upside: +4.03%
NetApp
Nov 22, 2024
Maintains: Buy
Price Target: $140 → $145
Current: $103.35
Upside: +40.30%
Nov 18, 2024
Initiates: Buy
Price Target: $28
Current: $24.75
Upside: +13.13%
Nov 5, 2024
Maintains: Hold
Price Target: $43 → $38
Current: $34.61
Upside: +9.79%
Aug 13, 2024
Upgrades: Buy
Price Target: $270 → $280
Current: $346.54
Upside: -19.20%
Aug 9, 2024
Maintains: Buy
Price Target: $3 → $2.5
Current: $2.62
Upside: -4.58%
Aug 9, 2024
Maintains: Hold
Price Target: $50 → $55
Current: $61.87
Upside: -11.10%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $24
Current: $97.48
Upside: -75.38%
Jul 17, 2024
Maintains: Buy
Price Target: $250 → $260
Current: $122.01
Upside: +113.10%
Jul 1, 2024
Initiates: Buy
Price Target: $18
Current: $0.76
Upside: +2,259.42%
Jun 13, 2024
Maintains: Hold
Price Target: $112 → $66
Current: $128.00
Upside: -48.44%
May 23, 2024
Maintains: Hold
Price Target: $80 → $90
Current: $77.21
Upside: +16.57%
Apr 3, 2024
Reiterates: Buy
Price Target: $25
Current: $18.58
Upside: +34.55%
Jan 25, 2024
Maintains: Hold
Price Target: $140 → $145
Current: $209.07
Upside: -30.65%
Sep 19, 2023
Maintains: Buy
Price Target: $110 → $120
Current: $186.92
Upside: -35.80%
Apr 19, 2023
Maintains: Buy
Price Target: $285 → $315
Current: $452.07
Upside: -30.32%
Apr 12, 2023
Downgrades: Hold
Price Target: $150
Current: $67.05
Upside: +123.71%
Oct 10, 2022
Maintains: Hold
Price Target: $130 → $105
Current: $145.85
Upside: -28.01%
Aug 11, 2022
Maintains: Hold
Price Target: $24 → $20
Current: $13.58
Upside: +47.28%
Nov 27, 2019
Maintains: Hold
Price Target: $15 → $20
Current: $0.58
Upside: +3,248.79%